The science and business of drug discovery : demystifying the jargon / Edward D. Zanders.
Zanders, Edward D., author.
2020
RM301.25 .Z36 2020
Available Online

Linked e-resources

Linked Resource Online Access
Concurrent users Unlimited
Authorized users Authorized users
Document Delivery Supplied Can lend chapters, not whole ebooks

Details

Title The science and business of drug discovery : demystifying the jargon / Edward D. Zanders.
Author Zanders, Edward D., author.
Edition Second edition.
ISBN 9783030578145 (electronic book)
3030578143 (electronic book)
3030578135
9783030578138
DOI https://doi.org/10.1007/978-3-030-57814-5
Published Cham, Switzerland : Springer, [2020]
Language English
Description 1 online resource
Other Standard Identifiers 10.1007/978-3-030-57814-5 doi
Call Number RM301.25 .Z36 2020
Dewey Decimal Classification 615.1/9
Bibliography, etc. Note Includes bibliographical references and index.
Access Note Access limited to authorized users.
Digital File Characteristics text file
Source of Description Online resource; title from PDF title page (SpringerLink, viewed January 28, 2021).
Available in Other Form Print version: 9783030578138
Linked Resources Online Access
Record Appears in Online Resources > Ebooks
All Resources
Introduction
PART 1: How Drugs are Discovered and Developed in the Pharmaceutical Industry
Introduction to Drugs and Drug Targets
Background to chemistry of small and large molecules
Laying the foundations- Drug discovery from antiquity to the twenty first century
Part II-The drug development pipeline - discovery to testing in humans
Drug discovery pipeline overview
Target discovery
Medicinal chemistry
Biotherapeutics
Screening for hits
Process chemistry and formulation
Preclinical development
Part III-The drug development pipeline - clinical trials to marketing authorisation
Clinical trials
Regulatory affairs and marketing approval
Diagnostics and personalized medicine
Putting it All Together: a drug development case history
Part IV- The Global Pharmaceuticals Business
Commercial aspects of drug development
Challenges and responses
Part V
Professional Interactions with the Drug Discovery Industry.-Professional Interactions with the Drug Discovery Industry: Technology Transfer Executives
Recruitment Executives
Pharmaceutical translators and Interpreters.

Browse Subjects

Show more subjects...

Statistics

from
to
Export